Start Over

BCL11A expression in acute phase chronic myeloid leukemia.

Authors :: Yin J
Zhang F
Tao H
Ma X
Su G
Xie X
Xu Z
Zheng Y
Liu H
He C
Mao ZJ
Wang Z
Chang W
Gale RP
Wu D
Yin B
Source :: Leukemia research [Leuk Res] 2016 Aug; Vol. 47, pp. 88-92. Date of Electronic Publication: 2016 May 24.
Publication Year :: 2016
Abstract: Chronic myeloid leukemia (CML) has chronic and acute phases. In chronic phase myeloid differentiation is preserved whereas in acute phase myeloid differentiation is blocked. Acute phase CML resembles acute myeloid leukemia (AML). Chronic phase CML is caused by BCR-ABL1. What additional mutation(s) cause transition to acute phase is unknown and may differ in different persons with CML. BCL11A encodes a transcription factor and is aberrantly-expressed in several haematological and solid neoplasms. We analyzed BCL11A mRNA levels in subjects with chronic and acute phase CML. BCL11A transcript levels were increased in subjects with CML in acute phase compared with those in normals and in subjects in chronic phase including some subjects studied in both phases. BCL11A mRNA levels were correlated with percent bone marrow blasts and significantly higher in lymphoid versus myeloid blast crisis. Differentiation of K562 with butyric acid, a CML cell line, decreased BCL11A mRNA levels. Cytology and flow cytometry analyses showed that ectopic expression of BCL11A in K562 cells blocked differentiation. These data suggest BCL11A may operate in transformation of CML from chronic to acute phase in some persons.<br /> (Copyright © 2016 Elsevier Ltd. All rights reserved.)